Bayer Secures FDA Clearance Expanding Capabilities of MEDRAD MRXperion MR Injection System

Clearance reinforces Bayer’s continued commitment to dependable, integrated radiology solutions Expanded Tesla compatibility captures low- to ...

March 06, 2026 | Friday | News
ImmunoScape Advances Seed And Boost Cancer Therapy Programme With United States Clinical Collaboration

The company also announced a strategic investment from Leonardo DiCaprio ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures an...

March 06, 2026 | Friday | News
Allosteric Bioscience Advances Integrated Platform To Decode And Control Molecular Drivers Of Aging

Allosteric Bioscience, Inc. is utilizing Genetics, Genomics, Systems Biology, Quantum Computing, Advanced Proprietary AI and Proprietary Molecular ...

March 06, 2026 | Friday | News
Codexis, Inc. Advances RNA Manufacturing with 50g siRNA Production Agreement for Cardiovascular Program

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing,  announced it has ent...

March 06, 2026 | Friday | News
Former BioDuro Leadership Launches Forma Life Sciences as Independent CDMO

-Forma Life Sciences, Inc. announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on o...

March 05, 2026 | Thursday | News
Forge Biologics to Manufacture PRF’s SamPro-2 Gene Therapy for IND Advancement

The Progeria Research Foundation (“PRF”), a nonprofit research organization dedicated to developing treatments and the cure for Hutchinson-Gi...

March 05, 2026 | Thursday | News
Ono and Congruence Deepen Strategic Discovery Alliance Beyond Oncology

Beginning a new drug discovery collaboration using Congruence’s globally recognized Revenir™ platform for the creation of small molecule ...

March 04, 2026 | Wednesday | News
Human-Centric AI: Accelerating Formulation Development Without Compromising Trust

As artificial intelligence becomes increasingly embedded in formulation science and early clinical planning, the industry faces a dual challenge: accelerat...

March 04, 2026 | Wednesday | Expert Opinion
Cipla USA Inc. Launches Generic Saxenda® in the U.S., Expanding Access to GLP-1 Weight Management Therapy

Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla")announced the launch of Li...

March 03, 2026 | Tuesday | News
Novo Nordisk Expands Sogroya® Label with Three New Pediatric Growth Disorder Indications

New indications expand treatment options for appropriate children aged 2.5 years and older with Idiopathic Short Stature (ISS), born Small for Ges...

March 03, 2026 | Tuesday | News
SciBase Holding AB Secures FDA Label Expansion to Broaden Clinical Use of Nevisense in U.S. Dermatology Practices

SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announced that it has received appro...

March 03, 2026 | Tuesday | News
Quotient Sciences and Ipsen Expand Commercial Manufacturing Partnership to Secure Supply of Ultra-Rare FOP Therapy

Quotient Sciences, a leading integrated CRDMO (Contract Research, Development and Manufacturing Organization), is pleased to announce an extended commerc...

March 02, 2026 | Monday | News
Designing Decarbonization: Embedding Sustainability at the Core of Life Sciences Infrastructure

As life sciences companies scale biologics, advanced therapies, and personalized medicines, sustainability has moved from aspiration to operational imperat...

March 02, 2026 | Monday | News
Integrated Partnerships for Enabling Agility in Biologics Development

As biologic modalities grow more complex and timelines compress, the operational relationship between contract development and manufacturing organizations ...

March 02, 2026 | Monday | Opinion

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close